Using a Stochastic Model to Detect Unusual Continuous Glucose Monitor Behaviour in Newborn Infants

Abstract Abnormal blood glucose (BG) concentrations have been associated with negative outcomes in critically ill adults and infants. Diagnosis of hyperglycaemia and hypoglycaemia is by BG measurements, which are typically taken several hours apart due to the clinical effort required. Continuous glucose monitoring (CGM) devices, which take measurements every 5 minutes, have the potential to improve the detection and diagnosis of these glycaemic abnormalities. There have been relatively few successful investigations of CGM devices in the ICU, and one study reported significant sensor noise. If CGM devices are going to be used in the clinical setting to monitor, diagnose and potentially help treat glycaemic abnormalities, clinicians need to know data are reliable and accurate. This study uses CGM data from neonatal infants to develop a tool that will aid clinicians in identifying unusual CGM behaviour. A stochastic model was created to classify CGM measurements with the aim of highlighting unusual CGM behaviour. In addition, the method uses a colour coded CGM trace to convey the information quickly and efficiently, either retrospectively or in real-time. The method has been used to detect unusual hypoglycaemic events and potential sensor degradation, both of which need to be interpreted with care. Overall, while BG measurements are required to make definitive conclusions about glycaemic events, the stochastic model provides another level of information to aid users in interpretation and decision making.

[1]  P. Watkinson,et al.  The effects of precision, haematocrit, pH and oxygen tension on point-of-care glucose measurement in critically ill patients: a prospective study , 2012, Annals of clinical biochemistry.

[2]  R. Dotsch,et al.  Hypoglycemia is associated with intensive care unit mortality* , 2010, Critical care medicine.

[3]  Michael Bailey,et al.  Hypoglycemia and outcome in critically ill patients. , 2010, Mayo Clinic proceedings.

[4]  Jay S Skyler,et al.  Continuous glucose monitoring: an overview of its development. , 2009, Diabetes technology & therapeutics.

[5]  J. Krinsley,et al.  Glycemic variability: A strong independent predictor of mortality in critically ill patients* , 2008, Critical care medicine.

[6]  Boris Kovatchev,et al.  Analysis, Modeling, and Simulation of the Accuracy of Continuous Glucose Sensors , 2008, Journal of diabetes science and technology.

[7]  J. Geoffrey Chase,et al.  Impact of Human Factors on Clinical Protocol Performance: A Proposed Assessment Framework and Case Examples , 2008, Journal of diabetes science and technology.

[8]  Christopher E. Hann,et al.  Stochastic modelling of insulin sensitivity and adaptive glycemic control for critical care , 2008, Comput. Methods Programs Biomed..

[9]  Rinaldo Bellomo,et al.  Variability of Blood Glucose Concentration and Short-term Mortality in Critically Ill Patients , 2006, Anesthesiology.

[10]  David C Klonoff,et al.  A review of continuous glucose monitoring technology. , 2005, Diabetes technology & therapeutics.

[11]  Boris Kovatchev,et al.  Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis. , 2005, Diabetes care.

[12]  Pascale Carayon,et al.  A human factors engineering conceptual framework of nursing workload and patient safety in intensive care units. , 2005, Intensive & critical care nursing.

[13]  Iain Mackenzie,et al.  Tight glycaemic control: a survey of intensive care practice in large English hospitals , 2005, Intensive Care Medicine.

[14]  D. Klonoff Continuous glucose monitoring: roadmap for 21st century diabetes therapy. , 2005, Diabetes care.

[15]  James D Dziura,et al.  Experience with the continuous glucose monitoring system in a medical intensive care unit. , 2004, Diabetes technology & therapeutics.

[16]  F. Chee,et al.  Expert PID control system for blood glucose control in critically ill patients , 2003, IEEE Transactions on Information Technology in Biomedicine.

[17]  James Stephen Krinsley,et al.  Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. , 2003, Mayo Clinic proceedings.

[18]  Timothy W. Evans,et al.  Glucose Control and Mortality in Critically Ill Patients , 2003 .

[19]  F. Chee,et al.  Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time , 2003, IEEE Transactions on Information Technology in Biomedicine.

[20]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[21]  B. Bistrian,et al.  Hyperglycemia and infection: which is the chicken and which is the egg? , 2001, JPEN. Journal of parenteral and enteral nutrition.

[22]  H. Gerstein,et al.  Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.

[23]  J. Stockman Continuous Glucose Monitoring in Newborn Babies at Risk of Hypoglycemia , 2012 .

[24]  George S. Cembrowski,et al.  The use of serial patient blood gas, electrolyte and glucose results to derive biologic variation: a new tool to assess the acceptability of intensive care unit testing , 2010, Clinical chemistry and laboratory medicine.

[25]  Liu Xinbing,et al.  Intensive insulin therapy for the critically ill patients with stress hyperglycemia , 2008 .